PSIP1 and systemic lupus erythematosus: Since anti-dsDNA antibodies have been regarded as one of the most important serological SLE biomarkers measured longitudinally in routine clinical practice for the assessment of disease activity (27), we once hypothesized a potential relationship of anti-DFS70 antibodies with disease activity in SLE.